Liver X receptors interfere with cytokine-induced proliferation and cell survival in normal and leukemic lymphocytes

Journal of Leukocyte Biology

Volumn 86, Issue 5, 2009, Pages 1039-1048

  Geyeregger, René ^a   Shehata, Medhat ^a   Zeyda, Maximilian ^a   Kiefer, Florian W ^a   Stuhlmeier, Karl M ^c   Porpaczy, Edit ^a   Zlabinger, Gerhard J ^b   Jäger, Ulrich ^a   Stulnig, Thomas M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

Cell cycle; T cell and B cell chronic lymphoblastic leukemia; T lymphoblasts

Indexed keywords

CYCLIN B; CYTOKINE; GELATINASE B; INTERLEUKIN 2; INTERLEUKIN 7; LIVER X RECEPTOR; PROTEIN BCL 2; RETINOBLASTOMA PROTEIN;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; BREAST CANCER; CANCER CELL; CELL CYCLE PROGRESSION; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CHRONIC LYMPHATIC LEUKEMIA; CYTOKINE PRODUCTION; DENDRITIC CELL; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNITY; LEUKEMIA CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE; UPREGULATION; WESTERN BLOTTING;

ANTIGENS, CD; CELL DIVISION; CELL SURVIVAL; CHOLESTEROL; CYTOKINES; HUMANS; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LEUKEMIA, PROLYMPHOCYTIC, T-CELL; LIPIDS; LYMPHOCYTES; METHYLPHENAZONIUM METHOSULFATE; ORPHAN NUCLEAR RECEPTORS; T-LYMPHOCYTES;

EID: 70350724700     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1008663     Document Type: Article

References (58)

1. Repa, J. J., Mangelsdorf, D. J. (2002) The liver X receptor gene team: potential new players in atherosclerosis. Nat. Med. 8, 1243-1248. (Pubitemid 35373555)
2. Geyeregger, R., Zeyda, M., Stulnig, T. M. (2006) Liver X receptors in cardiovascular and metabolic disease. Cell. Mol. Life Sci. 63, 524-539.
3. Castrillo, A., Tontonoz, P. (2004) Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation. Annu. Rev. Cell Dev. Biol. 20, 455-480. (Pubitemid 39488646)
4. Joseph, S. B., Castrillo, A., Laffitte, B. A., Mangelsdorf, D. J., Tontonoz, P. (2003) Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 9, 213-219. (Pubitemid 36227724)
5. Fowler, A. J., Sheu, M. Y., Schmuth, M., Kao, J., Fluhr, J. W., Rhein, L., Collins, J. L., Willson, T. M., Mangelsdorf, D. J., Elias, P. M., Feingold, K. R. (2003) Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: liver-X-receptor-specific inhibition of inflammation and primary cytokine production. J. Invest. Dermatol. 120, 246-255. (Pubitemid 36513075)
6. Hindinger, C., Hinton, D. R., Kirwin, S. J., Atkinson, R. D., Burnett, M. E., Bergmann, C. C., Stohlman, S. A. (2006) Liver X receptor activation decreases the severity of experimental autoimmune encephalomyelitis. J. Neurosci. Res. 84, 1225-1234. (Pubitemid 44654446)
7. Chintalacharuvu, S. R., Sandusky, G. E., Burris, T. P., Burmer, G. C., Nagpal, S. (2007) Liver X receptor is a therapeutic target in collagen-induced arthritis. Arthritis Rheum. 56, 1365-1367. (Pubitemid 46608662)
8. Giorelli, M., Livrea, P., Minervini, M. G., Trojano, M. (2007) Immunomodulatory properties of increased levels of liver X receptor β in peripheral blood mononuclear cells from multiple sclerosis patients. Exp. Neurol. 204, 759-766. (Pubitemid 46509501)
9. Geyeregger, R., Zeyda, M., Bauer, W., Kriehuber, E., Saemann, M. D., Zlabinger, G. J., Maurer, D., Stulnig, T. M. (2007) Liver X receptors regulate dendritic cell phenotype and function through blocked induction of the actin-bundling protein fascin. Blood 109, 4288-4295. (Pubitemid 46743395)
10. Walcher, D., Kummel, A., Kehrle, B., Bach, H., Grub, M., Durst, R., Hombach, V., Marx, N. (2006) LXR activation reduces proinflammatory cytokine expression in human CD4-positive lymphocytes. Arterioscler. Thromb. Vasc. Biol. 26, 1022-1028. (Pubitemid 43732107)
11. Bensinger, S. J., Bradley, M. N., Joseph, S. B., Zelcer, N., Janssen, E. M., Hausner, M. A., Shih, R., Parks, J. S., Edwards, P. A., Jamieson, B. D., Tontonoz, P. (2008) LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell 134, 97-111. (Pubitemid 351905740)
12. Chuu, C. P., Hiipakka, R. A., Kokontis, J. M., Fukuchi, J., Chen, R. Y., Liao, S. (2006) Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist. Cancer Res. 66, 6482-6486. (Pubitemid 44085600)
13. Gong, H., Guo, P., Zhai, Y., Zhou, J., Uppal, H., Jarzynka, M. J., Song, W. C., Cheng, S. Y., Xie, W. (2007) Estrogen deprivation and inhibition of breast cancer growth in vivo through activation of the orphan nuclear receptor liver X receptor. Mol. Endocrinol. 21, 1781-1790. (Pubitemid 47173791)
14. Nelson, B. H., Willerford, D. M. (1998) Biology of the interleukin-2 receptor. Adv. Immunol. 70, 1-81.
15. Brennan, P., Babbage, J. W., Burgering, B. M., Groner, B., Reif, K., Cantrell, D. A. (1997) Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F. Immunity 7, 679-689. (Pubitemid 28156635)
16. Barata, J. T., Keenan, T. D., Silva, A., Nadler, L. M., Boussiotis, V. A., Cardoso, A. A. (2004) Common γ chain-signaling cytokines promote proliferation of T-cell acute lymphoblastic leukemia. Haematologica 89, 1459-1467. (Pubitemid 39643513)
17. Zambricki, E., Shigeoka, A., Kishimoto, H., Sprent, J., Burakoff, S., Carpenter, C., Milford, E., McKay, D. (2005) Signaling T-cell survival and death by IL-2 and IL-15. Am. J. Transplant. 5, 2623-2631. (Pubitemid 43920055)
18. Nakamura, Y., Russell, S. M., Mess, S. A., Friedmann, M., Erdos, M., Francois, C., Jacques, Y., Adelstein, S., Leonard, W. J. (1994) Heterodimerization of the IL-2 receptor β- and γ-chain cytoplasmic domains is required for signaling. Nature 369, 330-333. (Pubitemid 24159545)
19. Leonard, W. J., O'Shea, J. J. (1998) Jaks and STATs: biological implications. Annu. Rev. Immunol. 16, 293-322.
20. Minami, Y., Taniguchi, T. (1995) IL-2 signaling: recruitment and activation of multiple protein tyrosine kinases by the components of the IL-2 receptor. Curr. Opin. Cell Biol. 7, 156-162.
21. Hunt, A. E., Lali, F. V., Lord, J. D., Nelson, B. H., Miyazaki, T., Tracey, K. J., Foxwell, B. M. (1999) Role of interleukin (IL)-2 receptor β-chain subdomains and Shc in p38 mitogen-activated protein (MAP) kinase and p54 MAP kinase (stress-activated protein Kinase/c-Jun N-terminal kinase) activation. IL-2-driven proliferation is independent of p38 and p54 MAP kinase activation. J. Biol. Chem. 274, 7591-7597. (Pubitemid 129505057)
22. Gu, H., Maeda, H., Moon, J. J., Lord, J. D., Yoakim, M., Nelson, B. H., Neel, B. G. (2000) New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway. Mol. Cell. Biol. 20, 7109-7120.
23. Gaffen, S. L., Lai, S. Y., Ha, M., Liu, X., Hennighausen, L., Greene, W. C., Goldsmith, M. A. (1996) Distinct tyrosine residues within the interleukin-2 receptor β chain drive signal transduction specificity, redundancy, and diversity. J. Biol. Chem. 271, 21381-21390. (Pubitemid 26293001)
24. Moriggl, R., Sexl, V., Piekorz, R., Topham, D., Ihle, J. N. (1999) Stat5 activation is uniquely associated with cytokine signaling in peripheral T cells. Immunity 11, 225-230. (Pubitemid 29428815)
25. Ng, J., Cantrell, D. (1997) STAT3 is a serine kinase target in T lymphocytes. Interleukin 2 and T cell antigen receptor signals converge upon serine 727. J. Biol. Chem. 272, 24542-24549. (Pubitemid 27418667)
26. Weinberg, R. A. (1995) The retinoblastoma protein and cell cycle control. Cell 81, 323-330.
27. Ewen, M. E., Sluss, H. K., Sherr, C. J., Matsushime, H., Kato, J., Livingston, D. M. (1993) Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73, 487-497. (Pubitemid 23143348)
28. Toyoshima, H., Hunter, T. (1994) p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78, 67-74. (Pubitemid 24228301)
29. Caligaris-Cappio, F., Hamblin, T. J. (1999) B-cell chronic lymphocytic leukemia: a bird of a different feather. J. Clin. Oncol. 17, 399-408. (Pubitemid 29022419)
30. Collins, R. J., Verschuer, L. A., Harmon, B. V., Prentice, R. L., Pope, J. H., Kerr, J. F. (1989) Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro. Br. J. Haematol. 71, 343-350.
31. Panayiotidis, P., Ganeshaguru, K., Jabbar, S. A., Hoffbrand, A. V. (1993) Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro. Br. J. Haematol. 85, 439-445. (Pubitemid 23349043)
32. Buschle, M., Campana, D., Carding, S. R., Richard, C., Hoffbrand, A. V., Brenner, M. K. (1993) Interferon γ inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J. Exp. Med. 177, 213-218. (Pubitemid 23008103)
33. Panayiotidis, P., Jones, D., Ganeshaguru, K., Foroni, L., Hoffbrand, A. V. (1996) Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. Br. J. Haematol. 92, 97-103. (Pubitemid 26018774)
34. Wolf, M. L., Buckley, J. A., Goldfarb, A., Law, C. L., LeBien, T. W. (1991) Development of a bone marrow culture for maintenance and growth of normal human B cell precursors. J. Immunol. 147, 3324-3330.
35. Kitada, S., Andersen, J., Akar, S., Zapata, J. M., Takayama, S., Krajewski, S., Wang, H. G., Zhang, X., Bullrich, F., Croce, C. M., Rai, K., Hines, J., Reed, J. C. (1998) Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses. Blood 91, 3379-3389. (Pubitemid 28193890)
36. Klein, A., Miera, O., Bauer, O., Golfier, S., Schriever, F. (2000) Chemosensitivity of B cell chronic lymphocytic leukemia and correlated expression of proteins regulating apoptosis, cell cycle and DNA repair. Leukemia 14, 40-46. (Pubitemid 30068371)
37. Meinhardt, G., Wendtner, C. M., Hallek, M. (1999) Molecular pathogenesis of chronic lymphocytic leukemia: factors and signaling pathways regulating cell growth and survival. J. Mol. Med. 77, 282-293. (Pubitemid 29146579)
38. Saemann, M. D., Parolini, O., Bohmig, G. A., Kelemen, P., Krieger, P. M., Neumuller, J., Knarr, K., Kammlander, W., Horl, W. H., Diakos, C., Stuhlmeier, K., Zlabinger, G. J. (2002) Bacterial metabolite interference with maturation of human monocyte-derived dendritic cells. J. Leukoc. Biol. 71, 238-246.
39. Hori, T., Uchiyama, T., Tsudo, M., Umadome, H., Ohno, H., Fukuhara, S., Kita, K., Uchino, H. (1987) Establishment of an interleukin 2-dependent human T cell line from a patient with T cell chronic lymphocytic leukemia who is not infected with human T cell leukemia/lymphoma virus. Blood 70, 1069-1072. (Pubitemid 18022384)
40. Zeyda, M., Saemann, M. D., Stuhlmeier, K. M., Mascher, D. G., Nowotny, P. N., Zlabinger, G. J., Waldhausl, W., Stulnig, T. M. (2005) Polyunsaturated fatty acids block dendritic cell activation and function independently of NF-κB activation. J. Biol. Chem. 280, 14293-14301. (Pubitemid 40517332)
41. Livak, K. J., Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Δ Δ C(T)) Method. Methods 25, 402-408. (Pubitemid 34164012)
42. Stuhlmeier, K. M., Tarn, C., Csizmadia, V., Bach, F. H. (1996) Selective suppression of endothelial cell activation by arachidonic acid. Eur. J. Immunol. 26, 1417-1423. (Pubitemid 26229983)
43. Li, Y., Bolten, C., Bhat, B. G., Woodring-Dietz, J., Li, S., Prayaga, S. K., Xia, C., Lala, D. S. (2002) Induction of human liver X receptor α gene expression via an autoregulatory loop mechanism. Mol. Endocrinol. 16, 506-514. (Pubitemid 34214570)
44. Quemeneur, L., Flacher, M., Gerland, L. M., Ffrench, M., Revillard, J. P., Bonnefoy-Berard, N. (2002) Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis. J. Immunol. 169, 2747-2755. (Pubitemid 34921024)
45. Frouin, I., Montecucco, A., Biamonti, G., Hubscher, U., Spadari, S., Maga, G. (2002) Cell cycle-dependent dynamic association of cyclin/Cdk complexes with human DNA replication proteins. EMBO J. 21, 2485-2495. (Pubitemid 34546720)
46. Casagrande, F., Bacqueville, D., Pillaire, M. J., Malecaze, F., Manenti, S., Breton-Douillon, M., Darbon, J. M. (1998) G1 phase arrest by the phosphatidylinositol 3-kinase inhibitor LY 294002 is correlated to up-regulation of p27Kip1 and inhibition of G1 CDKs in choroidal melanoma cells. FEBS Lett. 422, 385-390. (Pubitemid 28075501)
47. Fung, M. M., Rohwer, F., McGuire, K. L. (2003) IL-2 activation of a PI3K-dependent STAT3 serine phosphorylation pathway in primary human T cells. Cell. Signal. 15, 625-636. (Pubitemid 36385168)
48. Blaschke, F., Leppanen, O., Takata, Y., Caglayan, E., Liu, J., Fishbein, M. C., Kappert, K., Nakayama, K. I., Collins, A. R., Fleck, E., Hsueh, W. A., Law, R. E., Bruemmer, D. (2004) Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries. Circ. Res. 95, e110-e123.
49. Breslin, E. M., White, P. C., Shore, A. M., Clement, M., Brennan, P. (2005) LY294002 and rapamycin co-operate to inhibit T-cell proliferation. Br. J. Pharmacol. 144, 791-800. (Pubitemid 40516119)
50. Yamauchi, A., Bloom, E. T. (1997) Control of cell cycle progression in human natural killer cells through redox regulation of expression and phosphorylation of retinoblastoma gene product protein. Blood 89, 4092-4099. (Pubitemid 27220956)
51. Brennan, P., Babbage, J. W., Thomas, G., Cantrell, D. (1999) p70(s6k) integrates phosphatidylinositol 3-kinase and rapamycin-regulated signals for E2F regulation in T lymphocytes. Mol. Cell. Biol. 19, 4729-4738. (Pubitemid 29289511)
52. O'Brien, S., del Giglio, A., Keating, M. (1995) Advances in the biology and treatment of B-cell chronic lymphocytic leukemia. Blood 85, 307-318.
53. Ringshausen, I., Oelsner, M., Weick, K., Bogner, C., Peschel, C., Decker, T. (2006) Mechanisms of apoptosis-induction by rottlerin: therapeutic implications for B-CLL. Leukemia 20, 514-520. (Pubitemid 43291752)
54. Ringshausen, I., Dechow, T., Schneller, F., Weick, K., Oelsner, M., Peschel, C., Decker, T. (2004) Constitutive activation of the MAPkinase p38 is critical for MMP-9 production and survival of B-CLL cells on bone marrow stromal cells. Leukemia 18, 1964-1970. (Pubitemid 40028422)
55. Castrillo, A., Joseph, S. B., Marathe, C., Mangelsdorf, D. J., Tontonoz, P. (2003) Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages. J. Biol. Chem. 278, 10443-10449. (Pubitemid 36800310)
56. Shen, Y., Iqbal, J., Huang, J. Z., Zhou, G., Chan, W. C. (2004) BCL2 protein expression parallels its mRNA level in normal and malignant B cells. Blood 104, 2936-2939. (Pubitemid 39434983)
57. Findley, H. W., Gu, L., Yeager, A. M., Zhou, M. (1997) Expression and regulation of Bcl-2, Bcl-xl, and Bax correlate with p53 status and sensitivity to apoptosis in childhood acute lymphoblastic leukemia. Blood 89, 2986-2993. (Pubitemid 27172586)
58. Hanada, M., Delia, D., Aiello, A., Stadtmauer, E., Reed, J. C. (1993) bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 82, 1820-1828. (Pubitemid 23278773)